Mint Tower Capital Management
DAWN icon

Mint Tower Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Mint Tower Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60,000
Closed -$1.29M – 354
2026
Q1 		$1.29M Buy
+60,000
New +$845K 0.12% 153

Other funds holding DAWN

IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Mint Tower Capital Management's DAWN Position: Q2 2026 in Review

Mint Tower Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 60,000 shares — an estimated $1.29M sold.

Mint Tower Capital Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $1.29M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Mint Tower Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Mint Tower Capital Management sold 60,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.29M.
  • Mint Tower Capital Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Mint Tower Capital Management's Day One Biopharmaceuticals position peaked at $1.29M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Mint Tower Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.